Lifecore Biomedical to Participate at Upcoming Industry Conferences
Globe Newswire•07/10/2026•16:05 ET
0
Key Highlights
- ➤Lifecore will participate in three industry conferences from October through November 2026
- ➤Lifecore leaders will meet prospective customers about injectable process development and manufacturing services
- ➤Ryan Swanson will speak on high-dose, high-viscosity peptide and biologic delivery devices
Expert Statements
Ryan Swanson, Ph.D., Director of Lifecore’s Manufacturing Science & Technology group
“Designing Devices to Deliver High-Dose/High Viscosity Peptides & Biologics”
CHASKA, Minn., Oct. 07, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate at three upcoming industry events.
At each conference, Lifecore leaders will host meetings with prospective customers to discuss process development and manufacturing services for injectable programs. Details regarding Lifecore’s participation are as follows: * CDMO Live Americas: Booth number: C19 Conference Dates: October 19-21, 2026 Location: Boston, MA
Get started
Create a free account to read the full story.